SYRS - Syros Pharmaceuticals Inc. (SYRS) CEO Nancy Simonian on Q2 2021 Results - Earnings Call Transcript
Syros Pharmaceuticals, Inc. (SYRS) Q2 2021 Earnings Conference Call August 5, 2021 08:30 ET Company Participants Naomi Aoki - Vice President of Investor Relations & Corporate Communications Nancy Simonian - Chief Executive Officer David Roth - Chief Medical Officer Gerald Quirk - Chief Operations Officer Conference Call Participants Phil Nadeau - Cowen & Company Jason Butler - JMP Securities Mark Breidenbach - Oppenheimer Zegbeh Jallah - ROTH Capital Partners Ted Tenthoff - Piper Sandler Presentation Operator Good morning and welcome to Syros Pharmaceuticals Second Quarter 2021 Financial Results Conference Call. At this time, all participants are in listen-only mode. This call is being webcast live on the investors in media section of Syros' website at www.syros.com. Please be advised that today's call is being recorded. Following the formal remarks, we will open up the call for your questions. At this time, I would like to turn the call over to
For further details see:
Syros Pharmaceuticals, Inc. (SYRS) CEO Nancy Simonian on Q2 2021 Results - Earnings Call Transcript